Clinical Trial Update: Stereotactic Radiotherapy (SRT) Liver (COLD 1) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Stereotactic Radiotherapy (SRT) Liver (COLD 1) reporting completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms
• Neoplasm Metastases

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Neoplasms, Neoplasm Metastases | Phase 1, Phase 2 | Status: COMPLETED